Overview
Part of the book series: Ernst Schering Foundation Symposium Proceedings (SCHERING FOUND, volume 51)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (12 papers)
-
Front Matter
-
Back Matter
Keywords
About this book
Genome- and proteome-based research is generating a significant increase in the number of available drug targets. Correspondingly there is an increasing need for novel, diverse compounds, particularly based on natural compounds, as screening resource. The purpose of the Ernst Schering Research Foundation Workshop 51 was to provide a forum for an open exchange on perspectives and limitations of biocombinatorial synthesis and the significance of this technology for future drug discovery in light of this challenge. Experts from academia and industry provided contributions covering: the significance of natural compounds for state-of-the-art drug discovery; the underlying basic principle for the biosynthesis of highly complex compounds; and the scope and limitations of combinatorial biosynthesis regarding formation, identification, optimisation, isolation and manufacturing of novel biologically active entities.
Editors and Affiliations
Bibliographic Information
Book Title: Biocombinatorial Approaches for Drug Finding
Editors: W. Wohlleben, T. Spellig, B. Müller-Tiemann
Series Title: Ernst Schering Foundation Symposium Proceedings
DOI: https://doi.org/10.1007/b138552
Publisher: Springer Berlin, Heidelberg
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer-Verlag Berlin Heidelberg 2005
Hardcover ISBN: 978-3-540-22092-3Published: 29 November 2004
Softcover ISBN: 978-3-642-42189-1Published: 02 December 2014
eBook ISBN: 978-3-540-27055-3Published: 19 January 2007
Series ISSN: 0947-6075
Edition Number: 1
Number of Pages: XVIII, 284